These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13313809)

  • 21. Frenquel corrects certain cerebral electrographic changes.
    RINALDI F; HIMWICH HE
    Science; 1955 Jul; 122(3161):198-9. PubMed ID: 14396382
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies in human cerebral function: the effects of mescaline and lysergic acid on cerebral processes pertinent to creative activity.
    BERLIN L; GUTHRIE T; WEIDER A; GOODELL H; WOLFF HG
    J Nerv Ment Dis; 1955 Nov; 122(5):487-91. PubMed ID: 13320148
    [No Abstract]   [Full Text] [Related]  

  • 23. [Results of therapeutic tests of instinctive-affective reequilibration: test therapy of manic excitation syndromes with certain ergot derivatives (hydrogenated alkaloids, hydergin)].
    ABELY P; ABDOUCHELLI A; BEUCHER M; FOURMENT J
    Ann Med Psychol (Paris); 1952 May; 110(1 5):595-9. PubMed ID: 14944039
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of epileptic psychoses by vegetative block (Bolsi technic)].
    JARIA A
    Rass Studi Psichiatr; 1952; 41(2):226-35. PubMed ID: 14958055
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on human cerebral function: the effects of mescaline and lysergic acid on cerebral processes pertinent to creative activity.
    BERLIN L; GUTHRIE T; WEIDER A; GOODELL H; WOLFF HG
    Trans Am Neurol Assoc; 1955-1956; (80th Meeting):188-90. PubMed ID: 13312038
    [No Abstract]   [Full Text] [Related]  

  • 26. [Contribution to the psychopathological study of the effects of lysergic acid monoethylamide].
    CALLIERI B; RAVETTA M
    Arch Psicol Neurol Psichiatr; 1956; 17(1):43-79. PubMed ID: 13341385
    [No Abstract]   [Full Text] [Related]  

  • 27. [Electrical rhythms of the brain following administration of mescaline and lysergic acid (LSD 25) in mental disorders].
    SANGUINETI I; NEGRI VU; LARICCHIA R
    Riv Sper Freniatr Med Leg Alien Ment; 1955 Dec; 79(4):771-97. PubMed ID: 13311367
    [No Abstract]   [Full Text] [Related]  

  • 28. [Etiology of psychoses of the acute, exogenous reaction type; diethylamide of lysergic acid, a toxic trace element with psychic effects].
    BLICKENSTORFER E
    Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1952; 188(3):226-36. PubMed ID: 12977367
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of hallucinogenic and tranquilizing drugs on the serotonin-evoked uterine contractions.
    COSTA E
    Psychiatr Res Rep Am Psychiatr Assoc; 1956 Apr; (4):11-23. PubMed ID: 13323108
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of mescaline and L.S.D. on evoked responses especially of the optic system of the cat.
    ROVETTA P
    Electroencephalogr Clin Neurophysiol; 1956 Feb; 8(1):15-24. PubMed ID: 13294060
    [No Abstract]   [Full Text] [Related]  

  • 31. [Characteristic headache after prolonged use of ergot derivatives].
    LIPPMAN CW
    Rev Clin Esp; 1955 May; 57(4):232-5. PubMed ID: 13255202
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of maniacal syndromes by dihydrogenated alkaloids of ergot of rye (hydergine) associated with electroshock].
    POSTEL J; COSSA P; BERNUY M
    Ann Med Psychol (Paris); 1956 Jun; 114(1):75-80. PubMed ID: 13340372
    [No Abstract]   [Full Text] [Related]  

  • 33. Ergot as the cause of thromboangitis obliterans (Buerger's disease).
    KAUNITZ J
    Angiology; 1955 Dec; 6(6):556-66. PubMed ID: 13275762
    [No Abstract]   [Full Text] [Related]  

  • 34. Characteristic headache resulting from prolonged use of ergot derivatives.
    LIPPMAN CW
    J Nerv Ment Dis; 1955 Mar; 121(3):270-3. PubMed ID: 14381915
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives.
    CERLETTI A; ROTHLIN E
    Nature; 1955 Oct; 176(4486):785-6. PubMed ID: 13265830
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe arteriospastic disease secondary to use of ergot preparations.
    FAIRBAIRN JF
    Med Clin North Am; 1958 Jul; 42(4):971-4. PubMed ID: 13564981
    [No Abstract]   [Full Text] [Related]  

  • 37. Ergotism: a possible etiology for puerperal psychosis.
    Iffy L; Lindenthal JJ; McArdle JJ; McNamara RE; Szodi Z; Ganesh V
    Obstet Gynecol; 1989 Mar; 73(3 Pt 2):475-7. PubMed ID: 2915878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Body scheme disorders in lysergic acid diethylamide].
    ARNOLD OH; HOFF H
    Wien Z Nervenheilkd Grenzgeb; 1953; 6(4):259-74. PubMed ID: 13078611
    [No Abstract]   [Full Text] [Related]  

  • 39. [Poisoning with emedian].
    LAUX W
    S Afr J Clin Sci; 1953; 4(7):403-6. PubMed ID: 13146005
    [No Abstract]   [Full Text] [Related]  

  • 40. Ergonovine sensitivity and/or toxicity; report of a case.
    WRIGHT EN; GRAIEWSKI SJ
    Obstet Gynecol; 1955 Oct; 6(4):347-8. PubMed ID: 13254042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.